Precision BioSciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $189.28 million, with shareholders equity totaling $45.29 million.
The company employs approximately 231 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Precision BioSciences Inc. reported $45.05 million in revenue, generating net income of $-52.73 million.
Key financial metrics include a P/E ratio of -3.59, a price-to-book (P/B) ratio of 4.18, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker DTIL.